SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Vivo Bio Tech - Quaterly Results

20 May 2024 Evaluate
The sales is pegged at Rs. 115.50 millions for the March 2024 quarter. The mentioned figure indicates decline with the sales recorded at Rs. 144.00 millions during the year-ago period.The Company to register a -65.80%  fall in the net profit for the quarter ended March 2024.Operating profit for the quarter ended March 2024 decreased to 53.38 millions as compared to 71.26 millions of corresponding quarter ended March 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 115.50 144.00 -19.79 448.81 516.22 -13.06 448.81 516.22 -13.06
Other Income 0.09 0.20 -55.00 0.39 0.36 8.33 0.39 0.36 8.33
PBIDT 53.38 71.26 -25.09 211.23 215.23 -1.86 211.23 215.23 -1.86
Interest 15.18 20.14 -24.63 77.78 76.51 1.66 77.78 76.51 1.66
PBDT 38.20 51.12 -25.27 133.45 138.72 -3.80 133.45 138.72 -3.80
Depreciation 24.26 22.60 7.35 92.91 92.66 0.27 92.91 92.66 0.27
PBT 13.94 28.52 -51.12 40.54 46.06 -11.98 40.54 46.06 -11.98
TAX 6.97 8.14 -14.37 15.33 19.72 -22.26 15.33 19.72 -22.26
Deferred Tax -0.32 0.78 -141.03 -1.43 9.41 -115.20 -1.43 9.41 -115.20
PAT 6.97 20.38 -65.80 25.21 26.34 -4.29 25.21 26.34 -4.29
Equity 149.04 149.04 0.00 149.04 149.04 0.00 149.04 149.04 0.00
PBIDTM(%) 46.22 49.49 -6.61 47.06 41.69 12.88 47.06 41.69 12.88

Vivo Bio Tech Share Price

29.30 0.38 (1.31%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×